当前位置:首页 - 行情中心 - 联盛化学(301212) - 财务分析 - 利润表

联盛化学

(301212)

  

流通市值:32.56亿  总市值:37.51亿
流通股本:9375.00万   总股本:1.08亿

利润表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、营业总收入186,333,437.69693,391,059.26505,901,814.13342,887,861.57
  营业收入186,333,437.69693,391,059.26505,901,814.13342,887,861.57
二、营业总成本177,992,271.4682,334,546.01496,867,187.24325,591,374.64
  营业成本156,154,683.43612,809,928.74451,046,534.4299,439,412.6
  税金及附加1,280,222.224,526,015.652,905,097.971,997,008.87
  销售费用2,060,295.429,091,486.236,574,107.654,039,040.29
  管理费用10,723,674.3933,131,710.5823,049,734.6213,216,994.16
  研发费用6,572,073.7125,062,567.3215,861,723.049,714,338.03
  财务费用1,201,322.23-2,287,162.51-2,570,010.44-2,815,419.31
  其中:利息费用46,230.01101,423.0359,659.1532,885.15
  其中:利息收入341,832.384,921,324.113,743,271.543,119,708.48
三、其他经营收益
  加:公允价值变动收益-201,866.99-638,292.28-272,592.8124,079.09
  加:投资收益188,267.191,353,167.55999,879.5426,433.91
  资产处置收益-17,414.0517,414.0517,414.05
  资产减值损失(新)-394,774.8353,407.78-563,744.96-483,007.65
  信用减值损失(新)-830,430.24991,245.691,948,241.671,380,788.85
  其他收益856,742.494,903,077.683,256,944.162,525,030.87
四、营业利润7,959,103.9117,736,533.7214,420,768.5121,287,226.05
  加:营业外收入900.6367,876.9124,428.95124,228.12
  减:营业外支出13,166.34775,051363,042.98280,843.01
五、利润总额7,946,838.1717,329,359.6214,182,154.4821,130,611.16
  减:所得税费用837,988.18886,184.62415,008.152,535,985.36
六、净利润7,108,849.9916,443,17513,767,146.3318,594,625.8
(一)按经营持续性分类
  持续经营净利润7,108,849.9916,443,17513,767,146.3318,594,625.8
(二)按所有权归属分类
  归属于母公司股东的净利润6,091,187.5213,852,616.1412,414,342.0718,021,679.95
  少数股东损益1,017,662.472,590,558.861,352,804.26572,945.85
  扣除非经常损益后的净利润6,009,084.0811,371,614.0310,304,339.816,043,497.61
七、每股收益
  (一)基本每股收益0.060.130.110.17
  (二)稀释每股收益0.060.130.110.17
九、综合收益总额7,108,849.9916,443,17513,767,146.3318,594,625.8
  归属于母公司股东的综合收益总额6,091,187.5213,852,616.1412,414,342.0718,021,679.95
  归属于少数股东的综合收益总额1,017,662.472,590,558.861,352,804.26572,945.85
公告日期2026-04-242026-04-242025-10-302025-08-27
审计意见(境内)标准无保留意见
TOP↑